Abstract
The human mammary gland represents a highly organized and dynamic tissue, uniquely characterized by postnatal developmental cycles. During pregnancy and lactation, it undergoes extensive hormone-stimulated architectural remodeling, culminating in the formation of specialized structures for milk production to nourish offspring. Moreover, it carries significant health implications, due to the high prevalence of breast cancer. Therefore, gaining insight into the unique biology of the mammary gland can have implications for managing breast cancer and promoting the well-being of both women and infants. Tissue engineering techniques hold promise to narrow the translational gap between existing breast models and clinical outcomes. Here, we provide an overview of the current landscape of breast tissue engineering, outline key requirements, and the challenges to overcome for achieving more predictive human breast models. We propose methods to validate breast function and highlight preclinical applications for improved understanding and targeting of breast cancer. Beyond mammary gland physiology, representative human breast models can offer new insight into stem cell biology and developmental processes that could extend to other organs and clinical contexts.
Original language | English |
---|---|
Pages (from-to) | 2299 - 2321 |
Number of pages | 23 |
Journal | Embo Molecular Medicine |
Volume | 16 |
Issue number | 10 |
Early online date | 23 Aug 2024 |
DOIs | |
Publication status | Published - 14 Oct 2024 |
Keywords
- Bioprinting
- Human breast modeling
- Mammary gland biology
- Organ-on-a-chip
- Tissue engineering